| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1003997962 |
| P356 | DOI | 10.1007/S10096-015-2522-7 |
| P698 | PubMed publication ID | 26581426 |
| P2093 | author name string | R A A Pondé | |
| P2860 | cites work | Acute exacerbation of chronic hepatitis B: the dilemma of differentiation from acute viral hepatitis B | Q27022622 |
| Use of immunoglobulin G avidity assays for differentiation of primary from previous infections with West Nile virus | Q27472775 | ||
| Chronic hepatitis B: update 2009 | Q29617409 | ||
| Pathogenesis of hepatitis B virus infection | Q33925491 | ||
| Diagnosis and monitoring of hepatic injury. II. Recommendations for use of laboratory tests in screening, diagnosis, and monitoring | Q34098835 | ||
| Use of an anti-hepatitis C virus (HCV) IgG avidity assay to identify recent HCV infection | Q34120470 | ||
| Precision and accuracy of a procedure for detecting recent human immunodeficiency virus infections by calculating the antibody avidity index by an automated immunoassay-based method | Q34438290 | ||
| Molecular epidemiology and clinical characteristics of hepatitis B identified through the French mandatory notification system | Q35005494 | ||
| Immune responses in hepatitis B virus infection | Q35077626 | ||
| Differentiation of acute and chronic hepatitis B in IgM anti-HBc positive patients. | Q35270350 | ||
| Serum interleukin 6 level correlates with outcomes of acute exacerbation of chronic hepatitis B | Q57205299 | ||
| Higher cut-off index value of immunoglobulin M antibody to hepatitis B core antigen in Taiwanese patients with hepatitis B | Q57205374 | ||
| Occult hepatitis B virus infection | Q58811130 | ||
| Detection of serum HBV-DNA by polymerase chain reaction (PCR) in patients before reactivation of chronic hepatitis B | Q61045644 | ||
| Monitoring the natural course and response to therapy of chronic hepatitis B with an automated semi-quantitative assay for IgM anti-HBc | Q61054120 | ||
| Diagnostic significance of quantitative determination of hepatitis B surface antigen in acute and chronic hepatitis B infection. | Q64950332 | ||
| Prognostic significance of quantitative HBsAg determination in acute hepatitis B. Partial report of a cooperative clinical study of the DFG-focus of "virus hepatitis" | Q67069901 | ||
| 19S and 7-8S forms of IgM antibody to hepatitis B core antigen in acute icteric hepatitis superimposed on hepatitis B surface antigen carriage | Q68379476 | ||
| Reactivation of hepatitis B in a long-term anti-HBs-positive patient with AIDS following lamivudine withdrawal | Q77170031 | ||
| Kinetics of HBV DNA and HBsAg in acute hepatitis B patients with and without coinfection by other hepatitis viruses | Q78787040 | ||
| Fatal HBV reactivation in a subject with anti-HBs and anti-HBc | Q79923108 | ||
| Quantitative analysis of HBsAg, IgM anti-HBc and anti-HBc avidity in acute and chronic hepatitis B | Q80070164 | ||
| Differentiating acute hepatitis B from the first episode of symptomatic exacerbation of chronic hepatitis B | Q83155240 | ||
| A longitudinal study on the natural history of serum hepatitis B surface antigen changes in chronic hepatitis B | Q84583821 | ||
| Clinical utility of avidity assays | Q86398027 | ||
| Hepatitis B virus (HBV) DNA assays (methods and practical use) and viral kinetics | Q35621634 | ||
| Two distinct subtypes of hepatitis B virus-related acute liver failure are separable by quantitative serum immunoglobulin M anti-hepatitis B core antibody and hepatitis B virus DNA levels | Q35738189 | ||
| Kinetics of acute hepatitis B virus infection in humans. | Q36369106 | ||
| Cutoff levels of immunoglobulin M antibody against viral core antigen for differentiation of acute, chronic, and past hepatitis B virus infections | Q37208680 | ||
| Acute hepatitis B or exacerbation of chronic hepatitis B-that is the question | Q37351512 | ||
| Reactivation of hepatitis B. | Q37462566 | ||
| Hepatitis B surface antigen seroclearance during chronic HBV infection | Q37729640 | ||
| Prevention of hepatitis B virus reactivation in immunosuppressive therapy or chemotherapy | Q37883147 | ||
| Atypical serological profiles in hepatitis B virus infection | Q38063427 | ||
| Management of acute hepatitis B and reactivation of hepatitis B. | Q38071403 | ||
| Immunosuppression and HBV reactivation | Q38113184 | ||
| Bilirubin, aspartate aminotransferase and platelet count score: a novel score for differentiating patients with chronic hepatitis B with acute flare from acute hepatitis B. | Q38358084 | ||
| Reactivation of hepatitis B (reverse seroconversion) after melphalan/dexamethasone therapy for primary amyloidosis: a case report | Q38425549 | ||
| HBV-Specific Adaptive Immunity | Q38613247 | ||
| Hepatitis B surface antigen levels during the natural history of chronic hepatitis B: a perspective on Asia | Q39894574 | ||
| Screening cytomegalovirus, rubella and toxoplasma infections in pregnant women with unknown pre-pregnancy serological status | Q40207685 | ||
| Risks of chronicity following acute hepatitis B virus infection: a review | Q40552593 | ||
| Ten-year follow-up of hepatitis B relapse after cessation of lamivudine or telbivudine treatment in chronic hepatitis B patients | Q40647533 | ||
| Hepatic Failure Caused by Reactivation of YMDD Mutants Occurring during Preemptive Lamivudine Therapy | Q41120262 | ||
| Hepatitis B reactivation in multiple myeloma patients with resolved hepatitis B undergoing chemotherapy | Q41126737 | ||
| Immunological analysis of a patient with hepatitis B virus (HBV) reactivation after bone marrow transplantation | Q41221647 | ||
| Spontaneous reactivation of hepatitis B virus (HBV) infection in patients with resolved or occult HBV infection | Q41527993 | ||
| Hepatitis B virus reactivation and hepatitis in gastrointestinal cancer patients after chemotherapy | Q42163204 | ||
| Serum cytokine/chemokine profiles in acute exacerbation of chronic hepatitis B: clinical and mechanistic implications. | Q42224701 | ||
| Management of hepatitis B virus-related acute liver failure | Q42240045 | ||
| Immunosuppression in Patients with Chronic Hepatitis B. | Q42764680 | ||
| Reactivation of latent hepatitis B virus infection with HIV-related immunosuppression | Q44028612 | ||
| Core mutations in patients with acute episodes of chronic HBV infection are associated with the emergence of new immune recognition sites and the development of high IgM anti-HBc index values. | Q44126764 | ||
| Role of hepatitis B virus genotypes in chronic hepatitis B exacerbation | Q44541001 | ||
| Clinical, biochemical, immunological and virological profiles of, and differential diagnosis between, patients with acute hepatitis B and chronic hepatitis B with acute flare | Q44564223 | ||
| Usefulness of specific IgG avidity for diagnosis of hepatitis A infection | Q44604065 | ||
| High levels of hepatitis B virus after the onset of disease lead to chronic infection in patients with acute hepatitis B. | Q45351076 | ||
| Decreasing levels of HBsAg predict HBsAg seroclearance in patients with inactive chronic hepatitis B virus infection | Q45363616 | ||
| Hepatitis B surface antigen (HBsAg) levels in the natural history of hepatitis B virus (HBV)-infection: a European perspective. | Q45378210 | ||
| Breakthrough of hepatitis B virus escape mutants after vaccination and virus reactivation | Q45414695 | ||
| Anti-HBs-positive liver failure due to hepatitis B virus reactivation induced by rituximab | Q45414893 | ||
| Serum levels of interferon-α and-γ in acute and chronic hepatitis B virus infection | Q45788394 | ||
| Distinguishing between acute and symptomatic chronic hepatitis B virus infection | Q45789955 | ||
| IgM antibody to hepatitis B core antigen as a diagnostic parameter of acute infection with hepatitis B virus | Q45794310 | ||
| Low molecular weight (7s) immunoglobulin M antibody against hepatitis B core antigen in the serum for differentiating acute from persistent hepatitis B virus infection | Q45794608 | ||
| Low-molecular-weight IgM antibody to hepatitis B core antigen in chronic infections with hepatitis B virus | Q45795113 | ||
| The nucleocapsid of hepatitis B virus is both a T-cell-independent and a T-cell-dependent antigen | Q45831285 | ||
| Acute exacerbations in Chinese patients with chronic hepatitis B virus (HBV) infection. Incidence, predisposing factors and etiology | Q45849476 | ||
| Spontaneous reactivation in chronic hepatitis B: patterns and natural history | Q46073933 | ||
| Sustained HBeAg and HBsAg loss after long-term follow-up of HBeAg-positive patients treated with peginterferon alpha-2b | Q46514441 | ||
| Incubation phase of acute hepatitis B in man: dynamic of cellular immune mechanisms | Q57106837 | ||
| P433 | issue | 1 | |
| P921 | main subject | Hepatitis B virus | Q6844 |
| chronic hepatitis | Q62019625 | ||
| chronic hepatitis B | Q55779876 | ||
| P304 | page(s) | 29-40 | |
| P577 | publication date | 2015-11-18 | |
| P1433 | published in | European Journal of Clinical Microbiology & Infectious Diseases | Q15754378 |
| P1476 | title | Acute hepatitis B virus infection or acute exacerbation of chronic hepatitis B infection: the differential serological diagnosis | |
| P478 | volume | 35 |
Search more.